Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 1
Abstract
Hepatic involvement in primary amyloidosis is an infrequent challenge to the hepatologist. Although usually asymptomatic, amyloidosis may have unusual manifestations. Liver biopsy is an important diagnostic tool for this condition. Herein, we report three cases of portal hypertension related to primary hepatic amyloidosis, one of them in the form of acute liver failure.
Authors and Affiliations
Blanca Norero, Rosa María Pérez-Ayuso, Ignacio Duarte, Pablo Ramirez, Alejandro Soza, Marco Arrese, Carlos Benítez
On the cusp of change: New therapeutic modalities for HCV
We are at the cusp of significant new alternatives for the treatment of chronic hepatitis C. Among more than 100 drugs in development, some are ready to be approved and in the market as soon as next year. The protease in...
New insights into the pathophysiology of nonalcoholic fatty liver disease
The consequences of pathologic adipose tissue accumulation have been described for almost all organs. Nonalcoholic fatty liver disease (NAFLD) is considered the most relevant hepatic manifestation of obesity. There is gr...
The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients
Aim. To evaluate the diagnostic value of dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) in the differential diagnosis of hepatic angiomyolipoma (HAML) and hepatocellular carcinoma...
Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
Background. Serum levels of cystatin C, an endogenous inhibitor of cysteine proteases, provide an alternative method to creatinine-based criteria for measuring glomerular filtration rate. Preliminary data suggested that...
IN MEMORIAM-Professor Andrew Burroughs